AI aims to make smarter, safer choices for heart, cancer, and sepsis care
NCT ID NCT06694181
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study is developing and testing artificial intelligence (AI) tools to help doctors make personalized decisions for patients with heart disease, breast cancer, or sepsis. The AI will be designed to explain its recommendations clearly and ensure safety. Researchers will use data from up to 300,000 patients at Penn Medicine hospitals to train and evaluate these AI systems.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to AI systems that help doctors make safer, more personalized treatment decisions for heart disease, breast cancer, and sepsis.
What could go wrong
This is an early-stage study focused on developing and testing AI algorithms, not a treatment trial. It may not result in immediate clinical changes, and the AI recommendations will need further validation before widespread use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Hospital of the University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••